← Open Payments lookup

SUDHEERA RACHAMALLU: Open Payments

NPI 1629063789 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,429 in 71 payments from 15 companies in 2025. Trend: 2023 $1,481 · 2024 $1,554 · 2025 $1,429

Food & beverage: $1,428Education: $1
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$444
Vanda Pharmaceuticals Inc.8$179
Alkermes, Inc.6$148
ABBVIE INC.9$146
Otsuka America Pharmaceutical, Inc.6$108
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$106
Teva Pharmaceuticals USA, Inc.4$67
Corium, LLC5$52
E.R. Squibb & Sons, L.L.C.3$49
Luye Pharma (USA) Ltd.2$31

Products named: INGREZZA, FANAPT, VRAYLAR, ARISTADA, CAPLYTA, REXULTI, AUSTEDO XR, Azstarys.

Industry payments across LA — which companies pay providers there.